Bovie Medical Corp (BVX) 4.22 $BVX 5 Breakout S
Post# of 273221
![Avatar](/images/ProfileImages/410421673_9050_Stock_Tracker.jpg)
5 Breakout Stocks for Excellent Returns
Swarup Gupta - Zacks Investment Research - Fri Sep 16, 9:06AM CDT
Active investors often utilize a breakout investment strategy in the search for strong returns.
BVX: 4.22 (-0.02), FOMX: 10.20 (-0.08), CVGI: 5.66 (+0.01), KIN: 5.15 (-0.03), EXTR: 4.49 (unch)
Bovie Medical (BVX) Catches Eye: Stock Rises by 8.1%
Zacks Equity Research - Zacks Investment Research - Wed Sep 07, 7:00AM CDT
Bovie Medical Corporation (BVX) was a big mover last session, as the company saw its shares rise over 8% on the day.
GWPH: 107.56 (-2.20), BVX: 4.22 (-0.02)
Can Bovie Medical (BVX) Run Higher on Strong Earnings Estimate Revisions?
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 7:55AM CDT
Bovie Medical (BVX) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
BVX: 4.22 (-0.02)
Bovie J-Plasma(R) Precise 360(TM) Handpiece Named 'Innovation of the Year' by the Society of Laparoendoscopic Surgeons (SLS)
BusinessWire - Tue Aug 30, 7:20AM CDT
Bovie Medical (NYSE:BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, announced that the Bovie(R) J-Plasma(R) product extension, branded the Precise 360(TM), has been named an "Innovation of the Year" by The Society of Laparoendoscopic Surgeons (SLS).
BVX: 4.22 (-0.02)
3 Reasons Why Bovie Medical (BVX) is a Great Momentum Stock
Zacks Equity Research - Zacks Investment Research - Fri Aug 26, 7:37AM CDT
Bovie Medical Corporation (BVX) is looking especially impressive right now for momentum-oriented investors
BVX: 4.22 (-0.02)
Is Bovie Medical (BVX) a Great Growth Stock?
Zacks Equity Research - Zacks Investment Research - Wed Aug 24, 8:43AM CDT
Bovie Medical (BVX) has a favorable Zacks Rank and is a fast-growing stock that is well positioned for future earnings growth
BVX: 4.22 (-0.02)
Medovex Corporation Begins Commercial Production of DenerveX(TM) Pro-40 Generator in Preparation for EU Launch
Marketwired - Wed Aug 24, 7:00AM CDT
ATLANTA, GA--(Marketwired - Aug 24, 2016) - Medovex Corp. (NASDAQ: MDVX), a developer of medical technology products, today announced that it and its design and manufacturing partner Bovie Medical have commenced commercial production of the Company's DenerveX™ Pro-40 Power Generator as one more step towards the launch in the EU. Bovie Medical is a Florida based world leader in the development and manufacture of electrosurgical products.
MDVX: 1.70 (+0.03), BVX: 4.22 (-0.02)
Bovie Medical (BVX) Shares March Higher, Can It Continue?
Zacks Equity Research - Zacks Investment Research - Thu Aug 18, 9:43AM CDT
Bovie Medical Corporation (BVX) has been on the move lately as the stock has risen by more than 100% in the past four weeks, and it is currently trading well above its 20-Day SMA
BVX: 4.22 (-0.02)
Bovie Medical Receives FDA 510(k) Clearance for Its 'PlazXact(TM)' Ablator
BusinessWire - Tue Aug 16, 7:00AM CDT
--- Compatible with standard electrosurgical generators -
BVX: 4.22 (-0.02)
Bovie Medical (BVX) in Focus: Stock Jumps 10% in Session
Zacks Equity Research - Zacks Investment Research - Mon Aug 08, 7:05AM CDT
Bovie Medical Corporation (BVX) was a big mover last session, as the company saw its shares rise 10% on the day.
BVX: 4.22 (-0.02), LNTH: 8.49 (-0.58)
Bovie Medical Corporation Reports Second Quarter and First Half 2016 Results
BusinessWire - Mon Aug 01, 3:00PM CDT
--Second quarter revenue increased 27.8% year-over-year, driven by strong demand across the Company's product categories
BVX: 4.22 (-0.02)
Investor Calendar Invites You to the Bovie Medical Corporation Second Quarter 2016 Earnings Conference Call and Webcast Live on Monday, August 1, 2016
ACCESSWIRE - Mon Aug 01, 8:00AM CDT
CLEARWATER, FL / ACCESSWIRE / August 1, 2016 / Bovie Medical (NYSE MKT: BVX) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held Monday, August 1, 2016 at 4:30 PM Eastern Time.
BVX: 4.22 (-0.02)
Bovie Medical Corporation Reports First Quarter 2016 Results
BusinessWire - Wed May 11, 6:00AM CDT
--Total revenue increased 26.9%
BVX: 4.22 (-0.02)
Investor Calendar Invites You to the Bovie Medical Corporation First Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday, May 11, 2016
ACCESSWIRE - Tue May 10, 3:06PM CDT
CLEARWATER, FL / ACCESSWIRE / May 10, 2016 / Bovie Medical (NYSE MKT: BVX) will host a conference call and live webcast to discuss the results of the first quarter 2016, to be held Wednesday, May 11, 2016 at 8:00 AM Eastern Time.
BVX: 4.22 (-0.02)
Bovie Medical Corporation Announces Time Change for First Quarter 2016 Earnings Call
BusinessWire - Mon May 09, 7:00AM CDT
Bovie Medical (BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, today announced that it has changed the time of its first-quarter 2016 earnings conference call to 8:00 a.m. ET on Wednesday, May 11. The call was previously scheduled for Wednesday, May 11, at 8:30 a.m. ET.
BVX: 4.22 (-0.02)
Bovie Medical Corporation to Participate in Drexel Hamilton Micro-Cap Investor Forum
BusinessWire - Wed May 04, 7:00AM CDT
Bovie Medical Corporation ("Bovie" or the "Company"
![](/images/icons/icon_wink.gif)
BVX: 4.22 (-0.02)
Bovie Medical Corporation Announces First Quarter 2016 Earnings Call
BusinessWire - Wed Apr 27, 7:00AM CDT
Bovie Medical (BVX), a maker of medical devices and supplies and the developer of J-Plasma(R), a patented new surgical product, today announced that it will issue its financial results for the first quarter ended March 31, 2016 on Wednesday May 11, 2016 before market open.
BVX: 4.22 (-0.02)
Bovie Medical Corporation Announces Launch of J-Plasma(R) Precise 360(TM) and Its Application in Prostate Surgery Procedures
BusinessWire - Wed Apr 20, 7:00AM CDT
Bovie Medical Corporation, a maker of medical devices and supplies, and the developer of J-Plasma(R), a patented new surgical product, today announced the launch of its J-Plasma(R) product extension, branded the Precise 360(TM).
BVX: 4.22 (-0.02)
Bovie Medical Announces Completion of New J-Plasma(R) White Papers
BusinessWire - Mon Jan 11, 7:00AM CST
--- 10 white papers published on J-Plasma(R) to date
BVX: 4.22 (-0.02)
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)